Notch pathway inhibitors (AxoGlia Therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNotch pathway inhibitors (AxoGlia Therapeutics)
Drug Alias NameAGT-0031
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNotch-regulated ankyrin repeat-containing protein inhibitors
TargetsNotch-regulated ankyrin repeat-containing protein
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryLuxembourg
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAxoGlia Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAxoGlia Therapeutics SA
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A